Antipsychotic use has been rising in long-term care homes, but we can do something about it

"A new report has highlighted a concerning trend: as many as one in four long- term care residents may be prescribed antipsychotic medications unnecessarily."

Antipsychotic use in SNFs, assisted living and other long-term care facilities is often a double-edged sword. For facilities and care teams, managing side effects can be as challenging as the conditions they treat. Its even worse when patients are overprescribed or even misdiagnosed.

PGx testing has proven vital for these facilities - with many now requiring testing upon admittance. This empowers the care team with a unique genetic roadmap to provide a more precise, person-centred approach for each resident.

As stated in the article, "the rising trend in antipsychotic prescribing should serve as a wake-up call, but real change is possible when care teams come together and have tools and supports to focus on the whole person."

Click here to read the full article.